NLRC4 and shigellosis: Although mice are naturally resistance to oral Shigella inoculation, the Vance group has developed NAIP-NLRC4 inflammasome-deficient mouse model as a useful tool for in vivo investigations of mouse shigellosis (Mitchell et al, 2020).